No Detail Found!

Mean Blood Loss in Third Stage of Labour Treated with and without Prophylactic Tranexamic Acid

Author(s)
HAFIZA NAVEEDA KHURSHID Azra Naheed Medical College, CMA Hospital,Lahore,Pakistan
SAMAR NOOR Government Teaching Hospital Shahdrah,Pakistan
HUMA TASHEEN Azra Naheed Medical College, CMA Hospital,Lahore,Pakistan
SHABANA KHOKAR Rahbar Medical College, Ranger's Hospital,Pakistan
SOBIA SALEEM Government Teaching Hospital Shahdrah,Pakistan
Abstract
Massive obstetrical hemorrhage, a leading contributor towards maternal fatality in economically developing countries, is occasionally related with the passive and apathetic management of the third stage of labor. The increasing frequency of anaemia among pregnant women in developing countries, mild to moderate blood loss during labour necessitates massive transfusions with associated complications. Aim: Recent studies claimed that prophylactic tranexamic acid can significantly reduce the mean blood loss during 3rd stage of labour and advocated it in future practice. Methods: The research was conducted as randomized controlled trial carried out from February 2021 to October 2021 in the Department of Diagnostic Radiology and Obstetrics & Gynaecology Department, Ganga Ram Hospital, Lahore. A total of 116 pregnant women aged between 18-35 years presenting in labor at term (37-42 weeks of gestation as per dating scan) which were randomly allocated into two groups. Patients in Group-A were given additional tranexamic acid at the end of 2nd stage of labor while those in Group-B received conventional treatment alone. Results: Patients were 28.33±4.77 years with the mean age while the mean gestational age at delivery was 39.39±1.69 weeks. 30(25.9%) women were primiparas and 86 (74.1%) were multiaparas. The mean BMI of these patients was 27.50±3.90 Kg/m2 while the average duration of 3rd stage of labor was 4.69±1.83 minutes. Patients taking prophylactic tranexamic acid lost significantly less blood in the third stage of labors than controls (244.83±21.47 vs. 354.09±22.36 ml; p-value<0.001). Conclusion: In the present study, prophylactic tranexamic acid was found to significantly reduce the mean blood loss during 3rd stage of labor which along with low cost, widespread availability and oral administration advocates the routine use of tranexamic acid (during 3rd stage of labor) in future obstetric practice to minimize blood loss with subsequent decreased need for blood transfusion and better patient's recovery.
Publication Details
Page(s) 45-47
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 05, Year: 2022

Request the full text from PASTIC

Keywords
Blood loss, Tranexamic acid, Third Stage of Labor
References
Mundangepfupfu T,Waseem M. .2014 .Partial hydatidiform mole with falsenegative urine human chorionic gonadatropin test in the emergency department. J Emerg Med, 46(3) : 348-50.
Braga A,Growdon WB,Bernstein M,Maesta I,Rudge MV,Goldstein DP .2012 .Molar pregnancy in adolescents. J Reprod Med, 57(5- 6) : 225-30.
Fatima M,Kasi PM,Baloch SN,Kassi M,Marri SM,Kassi M .2011 .Incidence, management, and outcome of molar pregnancies at a tertiary care hospital in quetta, pakistan. Int Scholar Res Network Obstetr Gynecol, : .
Osborne R,Dodge J .2012 .Gestational trophoblastic neoplasia. Obstet Gynecol Clin North Am, 39(2) : 195-212.
Singh K. .2016 .Assessment of First Trimester Vaginal Bleeding Using Ultrasound Sonography. Asian J Biomed Pharmaceutical Sci, 6(57) : 54-6.
Black RE,Victora CG,Walker SP,Bhutta ZA,Christian P,de Onis M .2013 .Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet, 382(9890) : 427-51.
Okube OT,Mirie W,Odhiambo E,Sabina W,Habtu M. Prevalence .2016 .and factors associated with anaemia among pregnant women attending antenatal clinic in the second and third trimesters at pumwani maternity hospital. Kenya. Open J Obstet Gynecol, 6(1) : 16.
Msuya SE,Hussein TH,Uriyo J,Sam NE,Stray-Pedersen B .2011 .Anaemia among pregnant women in northern Tanzania: prevalence, risk factors and effect on perinatal outcomes. Tanzan J Health Res, 13(1) : 33-9.
Tandon R,Jain A,Malhotra P .2018 .Management of iron deficiency anemia in pregnancy in India. Indian J Hematol Blood Transfus, 34(2) : 204-15.
Pabinger I,Fries D,Schöchl H,Streif W,Toller W. .2017 .Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien Klin Wochenschr, 129(9) : 303-16.
Wang Y,Liu S,He L .2019 .Prophylactic use of tranexamic acid reduces blood loss and transfusion requirements in patients undergoing cesarean section: a meta-analysis. J Obstet Gynaecol Res, 45(8) : 1562-75.
Yang H,Zheng S,Shi C. .2001 .Clinical study on the efficacy of tranexamic acid in reducing postpartum blood lose: a randomized, comparative, multicenter trial. Zhonghua Fu Chan Ke Za Zhi, 36(10) : 590-2.
Shady NW,Sallam HF,Elsayed AH .2019 .The effect of prophylactic oral tranexamic acid plus buccal misoprostol on blood loss after vaginal delivery: a randomized controlled trial. J Matern Fetal Neonatal Med, 32(11) : 1806-12.
0

Citations

0

Downloads

52

Views